Clinic
Altamed Health Services Corp
Altamed Health Services Corp was paid $53.30M by Medicaid between Jan 2018 and Dec 2024, across 369 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 78% of everything it billed.
33Billing provider infoALTAMED HEALTH SERVICES CORP
HUNTINGTON BEACH, CA 92647
HUNTINGTON BEACH, CA 92647
33aNPI1306015425assigned 02/22/2008
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$53.30M
24GClaims2,504,860
24DCodes billed369
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in California
Rank by total paid#61 of 826
Median peer was paid$4.05M
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official YOUNG, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,320,076 | $7.74M | |
| 2019 | 543,773 | $6.36M | |
| 2020 | 92,017 | $6.75M | |
| 2021 | 121,885 | $8.00M | |
| 2022 | 116,291 | $6.81M | |
| 2023 | 147,833 | $9.48M | |
| 2024incomplete | 162,985 | $8.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 78% | 240,945 | 212,445 | $41.36M |
| 00003 | Internal/system code - not a standard HCPCS code | 19% | 41,586 | 39,414 | $9.97M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.0% | 358,713 | 303,982 | $556K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 62,267 | 52,115 | $298K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 6,234 | 5,152 | $114K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 65,546 | 60,125 | $103K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 9,021 | 7,832 | $101K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 10,964 | 9,689 | $85K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 5,593 | 4,761 | $79K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 4,804 | 3,126 | $67K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,950 | 1,621 | $43K |
| 90686 | <1% | 45,354 | 42,801 | $36K |
357 more codes
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 3,898 | $35K |
| G0467 | Community health center visit, returning patient | <1% | 1,484 | $32K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 1,971 | $31K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,591 | $31K |
| 92250 | <1% | 2,067 | $31K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,089 | $25K |
| J3490 | Unclassified drugs | <1% | 964 | $24K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 947 | $24K |
| 90677 | <1% | 1,013 | $21K | |
| 90715 | <1% | 7,978 | $18K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,269 | $17K |
| 90739 | <1% | 640 | $13K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,248 | $12K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,705 | $12K |
| 90651 | <1% | 5,314 | $10K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 4,682 | $10K |
| 92551 | <1% | 18,916 | $9K | |
| 90670 | <1% | 5,833 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15,537 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,425 | $8K |
| 0011A | <1% | 137 | $7K | |
| 85018 | <1% | 26,568 | $6K | |
| 0012A | <1% | 121 | $6K | |
| 90633 | <1% | 3,522 | $5K | |
| 90656 | <1% | 1,515 | $5K | |
| 90680 | <1% | 2,163 | $5K | |
| 83655 | <1% | 3,764 | $5K | |
| 90698 | <1% | 2,543 | $4K | |
| G9920 | Screening performed and negative | <1% | 2,538 | $4K |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 1,558 | $4K |
| 90734 | <1% | 2,661 | $4K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 5,662 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,059 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,730 | $4K |
| 81025 | <1% | 13,247 | $3K | |
| 90744 | <1% | 1,617 | $3K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 1,531 | $3K |
| 90688 | <1% | 2,640 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 9,890 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 33,776 | $2K |
| 99385 | <1% | 539 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 546 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 264 | $2K |
| 90710 | <1% | 1,250 | $2K | |
| 81002 | <1% | 34,011 | $2K | |
| 90658 | <1% | 161 | $1K | |
| 85999 | <1% | 492 | $1K | |
| 0064A | <1% | 28 | $1K | |
| 99384 | <1% | 287 | $1K | |
| 90716 | <1% | 991 | $1K | |
| 90696 | <1% | 892 | $1K | |
| 96156 | <1% | 536 | $874.87 | |
| 1126F | <1% | 149,086 | $853.95 | |
| 99173 | <1% | 17,216 | $810.78 | |
| 90707 | <1% | 911 | $721.13 | |
| 99401 | <1% | 1,856 | $706.67 | |
| 90697 | <1% | 946 | $684.00 | |
| 90732 | <1% | 572 | $649.86 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,168 | $623.48 |
| 90746 | <1% | 718 | $615.30 | |
| 90700 | <1% | 868 | $612.00 | |
| 90480 | <1% | 192 | $480.40 | |
| 90681 | <1% | 132 | $468.00 | |
| 90671 | <1% | 367 | $464.68 | |
| 90685 | <1% | 1,509 | $416.39 | |
| G9012 | Other specified case management service not elsewhere classified | <1% | 646 | $413.81 |
| 82962 | <1% | 4,000 | $381.42 | |
| 99383 | <1% | 324 | $353.65 | |
| 97803 | <1% | 729 | $336.40 | |
| 11721 | <1% | 151 | $302.25 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 31,136 | $300.97 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,974 | $248.33 |
| 99382 | <1% | 67 | $243.20 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,857 | $227.56 |
| 86580 | <1% | 1,357 | $214.94 | |
| 90648 | <1% | 1,125 | $211.04 | |
| 0124A | <1% | 15 | $201.00 | |
| 90750 | <1% | 12 | $176.03 | |
| 90619 | <1% | 452 | $126.00 | |
| 99243 | <1% | 319 | $124.41 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 53,002 | $117.70 |
| 90649 | <1% | 15 | $90.00 | |
| 36416 | <1% | 9,841 | $86.22 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 32 | $85.51 |
| 90713 | <1% | 187 | $72.00 | |
| 0144A | <1% | 15 | $67.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,050 | $56.97 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 9,886 | $41.70 |
| 80061 | Lipid panel | <1% | 24,582 | $34.62 |
| H2000 | Comprehensive multidisciplinary evaluation | <1% | 280 | $33.64 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 18,820 | $31.07 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16,570 | $29.52 |
| 80053 | Comprehensive metabolic panel | <1% | 29,268 | $27.84 |
| 90723 | <1% | 161 | $27.00 | |
| 99000 | <1% | 1,838 | $25.41 | |
| 96151 | <1% | 497 | $22.50 | |
| 81000 | <1% | 162 | $17.22 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 500 | $14.76 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,115 | $13.50 |
| 86803 | <1% | 3,720 | $12.57 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 245 | $10.56 |
| 81001 | <1% | 5,121 | $9.08 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 12,494 | $9.00 |
| 92015 | Determination of refractive state | <1% | 13 | $8.01 |
| 87070 | <1% | 789 | $7.95 | |
| 85027 | <1% | 2,179 | $5.71 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,503 | $2.21 |
| 82570 | <1% | 8,434 | $0.61 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 16 | $0.24 |
| 1160F | 0% | 98,143 | $0.00 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 0% | 1,108 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 1,578 | $0.00 |
| 69210 | 0% | 400 | $0.00 | |
| 1158F | 0% | 65,318 | $0.00 | |
| 3077F | 0% | 12,214 | $0.00 | |
| 3078F | 0% | 112,513 | $0.00 | |
| Z6400 | 0% | 2,708 | $0.00 | |
| 87512 | 0% | 110 | $0.00 | |
| 86003 | 0% | 339 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 4,874 | $0.00 |
| 1159F | 0% | 10,516 | $0.00 | |
| 0575F | 0% | 11,150 | $0.00 | |
| Z6500 | 0% | 12 | $0.00 | |
| 84450 | 0% | 118 | $0.00 | |
| 90461 | 0% | 7,673 | $0.00 | |
| 84550 | 0% | 368 | $0.00 | |
| 0502F | 0% | 7,667 | $0.00 | |
| 99242 | 0% | 65 | $0.00 | |
| 76802 | 0% | 223 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 18,732 | $0.00 |
| 91313 | 0% | 92 | $0.00 | |
| 80074 | 0% | 981 | $0.00 | |
| 86735 | 0% | 75 | $0.00 | |
| 84146 | 0% | 268 | $0.00 | |
| 85610 | 0% | 1,336 | $0.00 | |
| 82272 | 0% | 2,641 | $0.00 | |
| 87254 | 0% | 12 | $0.00 | |
| 85044 | 0% | 61 | $0.00 | |
| 86708 | 0% | 1,245 | $0.00 | |
| 73610 | 0% | 71 | $0.00 | |
| 84439 | 0% | 3,459 | $0.00 | |
| 3046F | 0% | 572 | $0.00 | |
| 86039 | 0% | 120 | $0.00 | |
| 80076 | 0% | 416 | $0.00 | |
| 82785 | 0% | 264 | $0.00 | |
| 87177 | 0% | 73 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 613 | $0.00 |
| 86431 | 0% | 238 | $0.00 | |
| J7699 | Noc drugs, inhalation solution administered through dme | 0% | 79 | $0.00 |
| 82274 | 0% | 2,650 | $0.00 | |
| 87660 | 0% | 876 | $0.00 | |
| 3045F | 0% | 478 | $0.00 | |
| 99442 | 0% | 640 | $0.00 | |
| 72100 | 0% | 83 | $0.00 | |
| 87075 | 0% | 236 | $0.00 | |
| 86038 | 0% | 374 | $0.00 | |
| Z6308 | 0% | 12 | $0.00 | |
| 76813 | 0% | 94 | $0.00 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 0% | 441 | $0.00 |
| 83013 | 0% | 233 | $0.00 | |
| 87338 | 0% | 621 | $0.00 | |
| 11981 | 0% | 206 | $0.00 | |
| 71046 | Radiologic examination, chest; 2 views | 0% | 326 | $0.00 |
| 86480 | 0% | 2,782 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 255 | $0.00 |
| 73130 | 0% | 27 | $0.00 | |
| 83540 | 0% | 711 | $0.00 | |
| 90687 | 0% | 128 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 278 | $0.00 |
| 84702 | 0% | 612 | $0.00 | |
| 81003 | 0% | 236 | $0.00 | |
| 84403 | 0% | 306 | $0.00 | |
| 88302 | 0% | 484 | $0.00 | |
| 76814 | 0% | 96 | $0.00 | |
| Z6304 | 0% | 106 | $0.00 | |
| 85007 | 0% | 245 | $0.00 | |
| 87210 | 0% | 108 | $0.00 | |
| 2024F | 0% | 460 | $0.00 | |
| 73630 | 0% | 46 | $0.00 | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 0% | 117 | $0.00 |
| 82947 | 0% | 144 | $0.00 | |
| 85045 | 0% | 62 | $0.00 | |
| 91321 | 0% | 41 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 97 | $0.00 |
| 96152 | 0% | 204 | $0.00 | |
| 84460 | 0% | 168 | $0.00 | |
| 86235 | 0% | 50 | $0.00 | |
| 86765 | 0% | 81 | $0.00 | |
| 3051F | 0% | 116 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 105 | $0.00 |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 0% | 103 | $0.00 |
| 59425 | 0% | 309 | $0.00 | |
| 2022F | 0% | 29 | $0.00 | |
| 87400 | 0% | 180 | $0.00 | |
| 86200 | 0% | 26 | $0.00 | |
| 73030 | 0% | 137 | $0.00 | |
| 90473 | 0% | 61 | $0.00 | |
| 87799 | 0% | 110 | $0.00 | |
| 84100 | 0% | 32 | $0.00 | |
| 73220 | 0% | 113 | $0.00 | |
| Z6300 | 0% | 71 | $0.00 | |
| 73562 | 0% | 144 | $0.00 | |
| 87045 | 0% | 78 | $0.00 | |
| Z6200 | 0% | 71 | $0.00 | |
| Z6414 | 0% | 15 | $0.00 | |
| 99348 | 0% | 67 | $0.00 | |
| 87481 | 0% | 110 | $0.00 | |
| 99201 | 0% | 12 | $0.00 | |
| 83721 | 0% | 27 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 0% | 44 | $0.00 |
| 17110 | 0% | 30 | $0.00 | |
| 82652 | 0% | 12 | $0.00 | |
| 98960 | 0% | 12 | $0.00 | |
| 91312 | 0% | 12 | $0.00 | |
| 86696 | 0% | 15 | $0.00 | |
| Z6208 | 0% | 12 | $0.00 | |
| 74018 | 0% | 12 | $0.00 | |
| 0521 | 0% | 72 | $0.00 | |
| 87209 | 0% | 61 | $0.00 | |
| 59426 | 0% | 17 | $0.00 | |
| 73702 | 0% | 12 | $0.00 | |
| 91320 | 0% | 17 | $0.00 | |
| 86787 | 0% | 13 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 26 | $0.00 |
| 11720 | 0% | 13 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 12 | $0.00 |
| 81508 | 0% | 15,708 | $0.00 | |
| 82607 | 0% | 902 | $0.00 | |
| 3074F | 0% | 111,024 | $0.00 | |
| 3008F | 0% | 8,539 | $0.00 | |
| 3351F | 0% | 146,651 | $0.00 | |
| 1125F | 0% | 32,011 | $0.00 | |
| 3079F | 0% | 26,327 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 83,758 | $0.00 |
| 86361 | 0% | 1,371 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 1,125 | $0.00 |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 3,317 | $0.00 |
| 73615 | 0% | 81 | $0.00 | |
| 83550 | 0% | 686 | $0.00 | |
| 0503F | 0% | 95 | $0.00 | |
| 87081 | 0% | 557 | $0.00 | |
| 86592 | 0% | 6,465 | $0.00 | |
| 86702 | 0% | 12,818 | $0.00 | |
| 86701 | 0% | 12,833 | $0.00 | |
| 0501F | 0% | 7,376 | $0.00 | |
| 3075F | 0% | 15,024 | $0.00 | |
| 86706 | 0% | 1,656 | $0.00 | |
| 73722 | 0% | 81 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 572 | $0.00 |
| 82043 | 0% | 8,353 | $0.00 | |
| 82270 | 0% | 2,648 | $0.00 | |
| Z1034 | 0% | 6,587 | $0.00 | |
| 86704 | 0% | 143 | $0.00 | |
| 83735 | 0% | 169 | $0.00 | |
| 84436 | 0% | 14 | $0.00 | |
| 3080F | 0% | 2,119 | $0.00 | |
| 87536 | 0% | 1,447 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 3,437 | $0.00 |
| 87510 | 0% | 873 | $0.00 | |
| 87625 | 0% | 4,386 | $0.00 | |
| 86140 | 0% | 526 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 3,349 | $0.00 |
| Z6410 | 0% | 2,078 | $0.00 | |
| 81005 | 0% | 81 | $0.00 | |
| 57454 | 0% | 227 | $0.00 | |
| 88142 | 0% | 269 | $0.00 | |
| 3353F | 0% | 1,662 | $0.00 | |
| 82746 | 0% | 848 | $0.00 | |
| 3352F | 0% | 354 | $0.00 | |
| 87480 | 0% | 872 | $0.00 | |
| 85651 | 0% | 764 | $0.00 | |
| 82150 | 0% | 115 | $0.00 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 157 | $0.00 |
| 82550 | 0% | 124 | $0.00 | |
| 87340 | 0% | 627 | $0.00 | |
| 3044F | 0% | 601 | $0.00 | |
| 83690 | 0% | 390 | $0.00 | |
| 83002 | 0% | 329 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 493 | $0.00 |
| 82271 | 0% | 2,642 | $0.00 | |
| 87046 | 0% | 79 | $0.00 | |
| 99241 | 0% | 341 | $0.00 | |
| Z6406 | 0% | 104 | $0.00 | |
| 82951 | 0% | 38 | $0.00 | |
| 87205 | 0% | 195 | $0.00 | |
| 0500F | 0% | 116 | $0.00 | |
| Z6204 | 0% | 134 | $0.00 | |
| Z1038 | 0% | 160 | $0.00 | |
| 93000 | 0% | 1,382 | $0.00 | |
| 82728 | 0% | 635 | $0.00 | |
| 96150 | 0% | 152 | $0.00 | |
| 84703 | 0% | 666 | $0.00 | |
| 3072F | 0% | 38 | $0.00 | |
| 82950 | 0% | 1,042 | $0.00 | |
| 85730 | 0% | 433 | $0.00 | |
| 84402 | 0% | 189 | $0.00 | |
| 84153 | 0% | 403 | $0.00 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 110 | $0.00 |
| 76641 | 0% | 80 | $0.00 | |
| J0456 | Injection, azithromycin, 500 mg | 0% | 155 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 66 | $0.00 |
| 86593 | 0% | 435 | $0.00 | |
| 1111F | 0% | 590 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 142 | $0.00 |
| 87522 | Neg quan hep c or qual rna | 0% | 56 | $0.00 |
| Z6402 | 0% | 83 | $0.00 | |
| 90647 | 0% | 52 | $0.00 | |
| 84144 | 0% | 16 | $0.00 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 0% | 385 | $0.00 |
| 58301 | 0% | 67 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 314 | $0.00 |
| 98962 | 0% | 349 | $0.00 | |
| 97802 | 0% | 221 | $0.00 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 0% | 43 | $0.00 |
| 82670 | 0% | 170 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 13 | $0.00 |
| 83519 | 0% | 204 | $0.00 | |
| 3354F | 0% | 127 | $0.00 | |
| S9452 | Nutrition classes, non-physician provider, per session | 0% | 333 | $0.00 |
| 85652 | 0% | 772 | $0.00 | |
| 84480 | 0% | 188 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 89 | $0.00 |
| 83001 | 0% | 432 | $0.00 | |
| 80055 | 0% | 577 | $0.00 | |
| 86695 | 0% | 12 | $0.00 | |
| 99050 | 0% | 758 | $0.00 | |
| Z1032 | 0% | 91 | $0.00 | |
| 27648 | 0% | 81 | $0.00 | |
| 76801 | 0% | 213 | $0.00 | |
| 90632 | 0% | 14 | $0.00 | |
| 86762 | 0% | 77 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 94 | $0.00 |
| 59430 | 0% | 25 | $0.00 | |
| 11976 | 0% | 67 | $0.00 | |
| 99381 | 0% | 115 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 0% | 86 | $0.00 |
| 99386 | 0% | 45 | $0.00 | |
| 87906 | 0% | 12 | $0.00 | |
| 0134A | 0% | 92 | $0.00 | |
| 87255 | 0% | 12 | $0.00 | |
| 81223 | 0% | 26 | $0.00 | |
| 84479 | 0% | 14 | $0.00 | |
| 11200 | 0% | 13 | $0.00 | |
| 86800 | 0% | 13 | $0.00 | |
| 58300 | 0% | 114 | $0.00 | |
| 86225 | 0% | 33 | $0.00 | |
| 84270 | 0% | 95 | $0.00 | |
| 99349 | 0% | 51 | $0.00 | |
| 91314 | 0% | 14 | $0.00 | |
| 94760 | 0% | 33 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 13 | $0.00 |
| 99283 | Emergency room visit (moderate) | 0% | 38 | $0.00 |
| 1170F | 0% | 15 | $0.00 | |
| 3052F | 0% | 19 | $0.00 | |
| 82105 | 0% | 15 | $0.00 | |
| 58100 | 0% | 12 | $0.00 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNG, ROBERT (VP, PATIENT FINANCIAL SERVICES)
| Provider | Location | Paid |
|---|---|---|
| Altamed Health Services Corp. | Los Angeles, CA | $305.80M |
| Altamed Health Services Corp | West Covina, CA | $83.90M |
| Altamed Health Services Corp | Pico Rivera, CA | $70.97M |
| Altamed Health Services Corp | El Monte, CA | $56.32M |
| Altamed Health Services Corp | Los Angeles, CA | $50.84M |
| Altamed Health Services Corp | Santa Ana, CA | $43.62M |
| Altamed Health Services Corp | Santa Ana, CA | $40.31M |
| Altamed Health Services Corp | E. Los Angeles, CA | $33.24M |
| Altamed Health Services Corp | Garden Grove, CA | $30.84M |
| Altamed Health Services Corp | Los Angeles, CA | $23.94M |
| Altamed Health Services Corp | Orange, CA | $19.54M |
| Altamed Health Services Corp | Pico Rivera, CA | $14.32M |
| Altamed Health Services Corp | Anaheim, CA | $7.95M |
| Robert L. Young, JR. , DDS | Charlotte, NC | $7.89M |
| Altamed Health Services Corp | Los Angeles, CA | $3.75M |
| Altamed Health Services Corp | Anaheim, CA | $3.62M |
| Altamed Health Services Corp | Anaheim, CA | $3.60M |
| Robert L Young 2 DDS PA | Mint Hill, NC | $2.39M |
| Altamed Health Services Corp | Los Angeles, CA | $2.03M |
| Altamed Health Services Corporation | Los Angeles, CA | $1.50M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.